Stage III Childhood Lymphoblastic Lymphoma Completed Phase 0 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0030479 (Stage III Childhood Lymphoblastic Lymphoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01959477Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell TransplantTreatment